Provided by Tiger Fintech (Singapore) Pte. Ltd.

Agios Pharmaceuticals

28.32
-1.6500-5.51%
Post-market: 28.320.00000.00%18:35 EDT
Volume:836.97K
Turnover:23.91M
Market Cap:1.64B
PE:2.47
High:30.02
Open:29.81
Low:27.78
Close:29.97
Loading ...
Jan 08, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Dec 09, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 22, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 14, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Nov 08, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Nov 04, 2019

Major Issues Report

Current report, item 8.01
Oct 31, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 31, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 28, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Oct 09, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Sep 30, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 04, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 01, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 01, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Jun 14, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 13, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 05, 2019

Major Issues Report

Current report, item 5.02
Jun 03, 2019

Major Issues Report

Current report, items 8.01 and 9.01
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 31, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities